PLYX
Polaryx Therapeutics·NASDAQ
--
--(--)
--
--(--)
PLYX Filings
Filing Date
Form Description
Form Type
2026-02-05
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2026-02-05 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2026-02-02
Form 424B4 - Prospectus [Rule 424(b)(4)]
2026-02-02 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2026-01-30
Form EFFECT - Notice of Effectiveness
2026-01-30 ·
Form EFFECT - Notice of Effectiveness
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
